00:01
Now 3 is replication.
00:03
We don't have any medications
to talk to you about today
for this specific phase.
00:07
So we've got him in
binding infusion,
conversion and integration,
but I don't have any specific
drugs to talk to you about today
in replication.
00:15
So we're going to move
on to that fourth phase
but just remember here's
what happens in replication.
00:21
The infected T helper cell
produces more HIV proteins.
00:25
These are used to produce
more HIV particles
inside the cell.
00:29
Replication makin copies.
00:32
So this is what we're
addressing there
and I don't have
any drugs for you
and that section the third,
but we're do have some options
in the assembly budding
and maturation stages.
00:43
Okay so here's what
goes on in the stage.
00:46
The new HIV particles are
released from the T helper cells
into the blood stream.
00:50
Now they begin to
infect other cells
and the process begins
again and again and again,
and again.
00:57
That's why keeping the number of
HIV viruses in the bloodstream
is our goal for the patient.
01:04
Now protease inhibitor drugs
stop this from happening.
01:08
So make sure you've got that
in your for stage or diagram
right in this the fourth stage
protease inhibitor drugs
because these are the
ones that stop this phase.
01:19
So they're among
the most effective
of the antiretroviral drugs.
01:23
Now there are nine available.
01:25
So we've got lots
of options there.
01:28
We using combinations
with an NRTI.
01:30
It can really help
reduce the viral load
to an undetectable level.
01:35
So you can see
that it's complex.
01:36
We've got a whole menu
of drugs to choose from
including just nine
in this category.
01:41
That's why the
healthcare provider
really make some decisions
in evaluating the patient
their ability to be compliant
their willingness
to use an injectable
and those other variables to see
what's going to be most
effective for them.
01:54
This like all the
others needs consistency
so that we can
prevent resistance.
02:00
So when you're thinking about
that concept as a nurse.
02:03
We are the ones who are the
guards, right?
We want to make sure
that patients understand
in a non-judgmental
non-threatening way
that hey we want these
drugs to be effective.
02:14
So really working towards
preventing resistance.
02:18
We want these drugs to
be effective for you
for a very long time.
02:22
That's another
encouragement to them
to take them consistently
or to problem solve with us
any issues that
arise why they can.
02:30
Now this group has some
different adverse effects
think of the effects
as a group overall
by the phase or the
stage in the lifecycle.
02:39
This one can
elevate blood sugar.
02:41
So protease Inhibitors
can really elevate blood sugar.
02:45
We're going to watch that very
closely and diabetic clients,
but in all clients.
02:50
You can also cause some kind
of unusual fat redistribution,
elevate their lipid
levels in their blood,
reduce their bone density
and no is after that, right?
It can increase bleeding people
that already have hemophilia.
03:04
So if the patient has
multiple disorders,
this is something that
has to be considered.
03:09
You know,
if the patient got HIV early
from a blood donor.
03:14
And because they're getting the
blood because of the hemophilia,
now they end up
with HIV you can see
how some people have a really
complicated course of therapy
that reduces bone density
and that resists the
mineral bone density.
03:27
So it's kind of the same thing there
that we've got it for you twice
just to really make a point.
03:32
We can also have an elevation
of serum transaminase.
03:36
Okay.
03:37
This is like a
whole list of things
that we've got for
you to look at.
03:41
So I want you to stop and pause
and take some time and think
about what your strategies
what works best in your brain
for you to group or chunk
this information together.
03:51
So you'll remember this
pretty significant list
of possible adverse effects
for a patient taking
a protease inhibitor.
04:04
So here's some examples.
04:05
Remember we told you
there are a lot of them.
04:07
Look at that.
04:08
What do they have in common?
When your brain is
taking a look at this?
What do you notice is the same
between every one of these
protease inhibitor medications?
Okay, they end in "VIR"
wait a minute even
one more letter
they end in AVIR.
04:25
So that is a clue to you
to recognize these as
protease inhibitor drugs.